NetworkNewsBreaks Archive - Page 2031 of 2178

MondayOct 02, 2017 11:54 am

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on October 2, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: ECYT 87.23% – News: In-licenses PSMA-617 from ABX GmbH RIGL 32.28% – News: Provides update from FDA meeting regarding Fostamatinib for ITP QTRH 21.98% – News: Posts financial update on Q3 2017 ATEC 21.02% – News: Names new executive chairman and member of the board SRAX 17.20% – News: Acquires demand-side platform from OpenDSP AMCT 13.98% – News: Names new CFO CPST 9.35% – News: Receives a C1000 Signature Series microturbine order ITUS 8.38%…

MondayOct 02, 2017 11:53 am

NetworkNewsBreaks – Mizuho Securities Reiterates “Buy” Rating on Aerie Pharmaceuticals, Inc. (NASDAQ: AERI)

Mizuho Securities USA LLC has reiterated its ‘Buy’ rating and price target of $70 on shares of Aerie Pharmaceuticals, Inc.’s (NASDAQ: AERI) stock after a Mizuho analyst spoke with company management regarding recent updates. Aerie’s shares have been weak since the company announced that its FDA advisory committee meeting on Rhopressa is scheduled for October 20. The analyst believes the weak shares represent a buying opportunity for investors. Additionally, the analysts noted that they believe the majority of the discussion at the meeting with the FDA on Rhopressa will be regarding potential side effects rather than efficacy. For more information,…

MondayOct 02, 2017 10:20 am

NetworkNewsBreaks – ORHub, Inc. (ORHB) Announces Completion of 2,000 Surgeries at Southern California Surgical Institution

Health care software-as-a-service company ORHub, Inc. (OTC: ORHB) this morning announced that it has successfully completed over 2,000 surgeries at a leading surgical institution in Southern California, putting it ahead of schedule as its national rollout strategy gets underway. “As a result of heightened awareness of the increasingly urgent need to streamline healthcare, we have met with dozens of inquiring surgical management teams from major institutions across the country, which collectively represent hundreds of hospitals,” Colt Melby, CEO of ORHub, stated in the news release. “We believe that ORHub's unrivaled technology will have a significant impact on hospital efficiency, profitability…

MondayOct 02, 2017 9:33 am

NetworkNewsBreaks – Patriot One Technologies, Inc. (TSX.V: PAT) (OTCQB: PTOTF) Achieves FCC Certification for PATSCAN CMR™

Patriot One Technologies, Inc. (TSX.V: PAT) (OTCQB: PTOTF) this morning announced that its award-winning PATSCAN CMR™ (Cognitive Microwave Radar) concealed weapons detection system has achieved Federal Communications Commission (FCC) Declaration of Conformity certification. “This is a momentous occasion for us,” Dinesh Kandanchatha, CTO of Patriot One, stated in the news release. “We now hold both FCC and Industry Canada (IC) certification allowing us to move into commercial roll-out across North America, with other countries soon to follow. The next stage of this exciting journey now begins with select deployments with key early adopters… We have used the waiting period for…

MondayOct 02, 2017 9:07 am

NetworkNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Names Fannie Tang as Marketing Director of CBD Biotechnology Co., Ltd.

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced that it has appointed skin care industry veteran and Shanghai beauty influencer Fannie (Chun Fang) Tang as marketing director of its wholly-owned CBD Biotechnology Co., Ltd. enterprise, effective immediately. Tang will be responsible for developing and implementing branding strategies for the company’s CBD Magic Hemp Series skin care line in China. “With over twenty years of marketing and branding experience in the skin care and cosmetics industry, I believe CBD Biotechnology is extremely fortunate to be working with Ms. Tang,” Summer Yun, CEO of CBD Biotechnology, stated in the news…

FridaySep 29, 2017 2:46 pm

NetworkNewsBreaks – HighCom Global Security (HCGS) Adheres to Highest Quality Standards in Bringing New Security and Defense Products to Market

HighCom Global Security, Inc. (OTC: HCGS), a leading provider of blast effects mitigation solutions along with other equipment and services for the security and defense industries, has brought several new products to the market during 2017 while upholding its ISO 9001:2008-certified Quality Management System, which has been in place since 2005 and was certified in 2006. This system helps ensure approval of all HighCom’s products by the International Organization for Standardization (ISO). An article further discussing this reads: “The company serves law enforcement, military and government customers, as well as those in the commercial sector. It can offer fire suppression…

FridaySep 29, 2017 2:44 pm

NetworkNewsBreaks – Algae Dynamics Corp. (ADYNF) Collaborative Study Yields Possible Breakthrough in Reversing Mental Illness Symptoms Resulting from Adolescent Cannabis Use

Algae Dynamics Corp. (OTCQB: ADYNF), a company engaged in developing unique health products and pharmaceuticals that utilize hemp, cannabis and algae oils, is making international news through its current collaboration with the University of Western Ontario (now rebranded as Western University). A recent study conducted collaboratively between the two entities and globally reported (http://nnw.fm/aJ7Oh) has found that the negative effects of tetrahydrocannabinol (THC)-rich marijuana on the adolescent brain can be reversed through the use of compounds that increase the amounts of GABA, which is a chemical and neurotransmitter in the brain. An article further discussing this reads: “THC exposure reduced…

FridaySep 29, 2017 2:41 pm

NetworkNewsBreaks – ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Achieves $43M in Working Capital, Eyes Substantial Production Capacity Increase for 2018

ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF), a manufacturer and distributor of medical cannabis in Canada, announced on August 29 (http://nnw.fm/Wk1ly) the achievement of working capital in the amount of $43 million from multiple financings, including strategic partnerships and private placements, during the six months ended June 30, 2017. During that period, ABcann recorded revenues of C$264,319, compared with $21,465 during the same period of 2016. For the six-month period ended June 30, the company’s revenues were $436,802, as compared with $21,840 for comparable period of the previous year. An article further discussing this reads: “ABcann’s first quarter as a…

FridaySep 29, 2017 2:38 pm

NetworkNewsBreaks – Zogenix, Inc. (NASDAQ: ZGNX) Shares Soar on Positive Phase 3 Trial of ZX008; Reaffirmed with ‘Buy’ Rating at Mizuho

Shares of Zogenix, Inc. (NASDAQ: ZGNX) clipped a new 52-week high earlier today after the company said its ZX008 for Dravet Syndrome (DS) met its primary endpoint in a phase 3 trial. ZX008 is designated as an orphan drug in both the U.S. and Europe, and it has received Fast Track designation in the U.S. for the treatment of DS. “On behalf of everyone at Zogenix, I would like to extend my sincere appreciation to the patients, families and investigators involved in this study. We are extremely pleased with the top-line efficacy and safety results from Study 1 which reinforce the…

FridaySep 29, 2017 12:00 pm

NetworkNewsBreaks – Mizuho Securities Reiterates ‘Buy’ Rating on Achaogen, Inc. (NASDAQ: AKAO)

Mizuho Securities USA LLC has reiterated its ‘Buy’ rating and price target of $28 on shares of Achaogen, Inc.’s (NASDAQ: AKAO) stock after the company yesterday said that it has been awarded a contract valued at up to $18 million in funding from the Biomedical Advanced Research and Development Authority (BARDA). The funding will support the development of C-Scape, Achaogen’s product candidate being developed to treat serious bacterial infections due to extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae. The BARDA contract comprises of $12 million of funding through a nine-month base period and additional option periods worth around $6 million. The analyst…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks